Dr. Samantha Brugmann | Brugmann Lab

Bio:

Dr. Samantha Brugmann is a developmental biologist studying craniofacial development and disease. Her longterm goal is to help children with craniofacial anomalies by generating tissue amenable for surgical repair. To achieve this goal, her lab specifically focuses on the role the primary cilium during craniofacial development and the craniofacial anomalies that arise when the cilium do not function properly. Projects in her lab utilize avian, murine and humaninduced pluripotent stem cells to gain a better understanding of the molecular mechanisms associated with craniofacial anomalies. In addition to using existing animal models to understand human craniofacial disorders, her lab also sequences patients and generates cell-based models to uncover novel genetic causes for craniofacial ciliopathies.



Abstract:

The Brugmann Lab focuses on the understanding molecular and cellular processes important for craniofacial development and the onset of craniofacial anomalies (CFAs). CFAs represent approximately one third of all birth-defects. For the past decade, my research program has centered on treating these conditions by garnering a fundamental understanding of craniofacial development and pathological mechanisms associated with CFAs. We have specifically focused on a class of CFAs called ciliopathies, which are caused by disruptions to a cellular organelle called the primary cilium. Ciliopathies represent a fast-growing group of disorders, that can affect up to 1 in 800 people. My lab was the first to report that the craniofacial complex is the primary organ system affected in 30% of all ciliopathies, and thus coined the term craniofacial ciliopathies. My lab uses murine, avian and human model systems to understand molecular mechanisms associated with ciliopathies. Furthermore, we use these model systems to identify potential therapeutic avenues to treat this class of diseases. 

Dr. Samantha Brugmann | Brugmann Lab

Bio:

Dr. Samantha Brugmann is a developmental biologist studying craniofacial development and disease. Her longterm goal is to help children with craniofacial anomalies by generating tissue amenable for surgical repair. To achieve this goal, her lab specifically focuses on the role the primary cilium during craniofacial development and the craniofacial anomalies that arise when the cilium do not function properly. Projects in her lab utilize avian, murine and humaninduced pluripotent stem cells to gain a better understanding of the molecular mechanisms associated with craniofacial anomalies. In addition to using existing animal models to understand human craniofacial disorders, her lab also sequences patients and generates cell-based models to uncover novel genetic causes for craniofacial ciliopathies.



Abstract:

The Brugmann Lab focuses on the understanding molecular and cellular processes important for craniofacial development and the onset of craniofacial anomalies (CFAs). CFAs represent approximately one third of all birth-defects. For the past decade, my research program has centered on treating these conditions by garnering a fundamental understanding of craniofacial development and pathological mechanisms associated with CFAs. We have specifically focused on a class of CFAs called ciliopathies, which are caused by disruptions to a cellular organelle called the primary cilium. Ciliopathies represent a fast-growing group of disorders, that can affect up to 1 in 800 people. My lab was the first to report that the craniofacial complex is the primary organ system affected in 30% of all ciliopathies, and thus coined the term craniofacial ciliopathies. My lab uses murine, avian and human model systems to understand molecular mechanisms associated with ciliopathies. Furthermore, we use these model systems to identify potential therapeutic avenues to treat this class of diseases. 

Dr. Samantha Brugmann | Brugmann Lab

Bio:

Dr. Samantha Brugmann is a developmental biologist studying craniofacial development and disease. Her longterm goal is to help children with craniofacial anomalies by generating tissue amenable for surgical repair. To achieve this goal, her lab specifically focuses on the role the primary cilium during craniofacial development and the craniofacial anomalies that arise when the cilium do not function properly. Projects in her lab utilize avian, murine and humaninduced pluripotent stem cells to gain a better understanding of the molecular mechanisms associated with craniofacial anomalies. In addition to using existing animal models to understand human craniofacial disorders, her lab also sequences patients and generates cell-based models to uncover novel genetic causes for craniofacial ciliopathies.



Abstract:

The Brugmann Lab focuses on the understanding molecular and cellular processes important for craniofacial development and the onset of craniofacial anomalies (CFAs). CFAs represent approximately one third of all birth-defects. For the past decade, my research program has centered on treating these conditions by garnering a fundamental understanding of craniofacial development and pathological mechanisms associated with CFAs. We have specifically focused on a class of CFAs called ciliopathies, which are caused by disruptions to a cellular organelle called the primary cilium. Ciliopathies represent a fast-growing group of disorders, that can affect up to 1 in 800 people. My lab was the first to report that the craniofacial complex is the primary organ system affected in 30% of all ciliopathies, and thus coined the term craniofacial ciliopathies. My lab uses murine, avian and human model systems to understand molecular mechanisms associated with ciliopathies. Furthermore, we use these model systems to identify potential therapeutic avenues to treat this class of diseases. 

Dr. Carrie Adler | Adler Lab

Bio:

Carrie is currently an Assistant Professor in the Department of Molecular Medicine at Cornell University, where she started her lab in 2015. She attended college at Wesleyan University and afterwards worked as a technician with Bruce Mayer at Harvard Medical School, studying signal transduction pathways. For graduate school, Carrie enrolled in the Tetrad program at UCSF, joining Cori Bargmann's lab to study neural development in C. elegans. As a postdoc, Carrie trained with Alejandro Sánchez Alvarado at the University of Utah and the Stowers Institute for Medical Research.

Abstract:

Throughout our lives, we are constantly exposed to insults, including injuries, disease, and environmental toxins. Frequently referred to as a ‘fountain of youth’ given their potential for rejuvenation, stem cells have the capacity to restore damaged tissue. In most model organisms, regenerative capacity is limited and stem cells are scarce, which has made it difficult to pinpoint the mechanisms regulating their behavior. In addition, stem cell exhaustion occurs as we age, diminishing our ability to repair damaged tissues. Finally, while we have made significant progress in recapitulating organ growth in vitro, how might these tissues be used in humans to restore physiological function?

My research program has probed these questions in an emerging model organism, planarian flatworms. These animals have long been regarded as champion regenerators because they can rapidly replace any tissue that’s been damaged or lost, including the nervous system. The basis of this unlimited renewal lies in an abundant population of stem cells. My lab’s primary goals are to understand how these cells sense and respond to injury, and how they maintain genome integrity through repeated cell divisions that occur during regeneration.

Check out the seminar here!

Dr. Carrie Adler | Adler Lab

Bio:

Carrie is currently an Assistant Professor in the Department of Molecular Medicine at Cornell University, where she started her lab in 2015. She attended college at Wesleyan University and afterwards worked as a technician with Bruce Mayer at Harvard Medical School, studying signal transduction pathways. For graduate school, Carrie enrolled in the Tetrad program at UCSF, joining Cori Bargmann's lab to study neural development in C. elegans. As a postdoc, Carrie trained with Alejandro Sánchez Alvarado at the University of Utah and the Stowers Institute for Medical Research.

Abstract:

Throughout our lives, we are constantly exposed to insults, including injuries, disease, and environmental toxins. Frequently referred to as a ‘fountain of youth’ given their potential for rejuvenation, stem cells have the capacity to restore damaged tissue. In most model organisms, regenerative capacity is limited and stem cells are scarce, which has made it difficult to pinpoint the mechanisms regulating their behavior. In addition, stem cell exhaustion occurs as we age, diminishing our ability to repair damaged tissues. Finally, while we have made significant progress in recapitulating organ growth in vitro, how might these tissues be used in humans to restore physiological function?

My research program has probed these questions in an emerging model organism, planarian flatworms. These animals have long been regarded as champion regenerators because they can rapidly replace any tissue that’s been damaged or lost, including the nervous system. The basis of this unlimited renewal lies in an abundant population of stem cells. My lab’s primary goals are to understand how these cells sense and respond to injury, and how they maintain genome integrity through repeated cell divisions that occur during regeneration.

Check out the seminar here!

Dr. Carrie Adler | Adler Lab

Bio:

Carrie is currently an Assistant Professor in the Department of Molecular Medicine at Cornell University, where she started her lab in 2015. She attended college at Wesleyan University and afterwards worked as a technician with Bruce Mayer at Harvard Medical School, studying signal transduction pathways. For graduate school, Carrie enrolled in the Tetrad program at UCSF, joining Cori Bargmann's lab to study neural development in C. elegans. As a postdoc, Carrie trained with Alejandro Sánchez Alvarado at the University of Utah and the Stowers Institute for Medical Research.

Abstract:

Throughout our lives, we are constantly exposed to insults, including injuries, disease, and environmental toxins. Frequently referred to as a ‘fountain of youth’ given their potential for rejuvenation, stem cells have the capacity to restore damaged tissue. In most model organisms, regenerative capacity is limited and stem cells are scarce, which has made it difficult to pinpoint the mechanisms regulating their behavior. In addition, stem cell exhaustion occurs as we age, diminishing our ability to repair damaged tissues. Finally, while we have made significant progress in recapitulating organ growth in vitro, how might these tissues be used in humans to restore physiological function?

My research program has probed these questions in an emerging model organism, planarian flatworms. These animals have long been regarded as champion regenerators because they can rapidly replace any tissue that’s been damaged or lost, including the nervous system. The basis of this unlimited renewal lies in an abundant population of stem cells. My lab’s primary goals are to understand how these cells sense and respond to injury, and how they maintain genome integrity through repeated cell divisions that occur during regeneration.

Check out the seminar here!

Dr. Carrie Adler | Adler Lab

Bio:

Carrie is currently an Assistant Professor in the Department of Molecular Medicine at Cornell University, where she started her lab in 2015. She attended college at Wesleyan University and afterwards worked as a technician with Bruce Mayer at Harvard Medical School, studying signal transduction pathways. For graduate school, Carrie enrolled in the Tetrad program at UCSF, joining Cori Bargmann's lab to study neural development in C. elegans. As a postdoc, Carrie trained with Alejandro Sánchez Alvarado at the University of Utah and the Stowers Institute for Medical Research.

Abstract:

Throughout our lives, we are constantly exposed to insults, including injuries, disease, and environmental toxins. Frequently referred to as a ‘fountain of youth’ given their potential for rejuvenation, stem cells have the capacity to restore damaged tissue. In most model organisms, regenerative capacity is limited and stem cells are scarce, which has made it difficult to pinpoint the mechanisms regulating their behavior. In addition, stem cell exhaustion occurs as we age, diminishing our ability to repair damaged tissues. Finally, while we have made significant progress in recapitulating organ growth in vitro, how might these tissues be used in humans to restore physiological function?

My research program has probed these questions in an emerging model organism, planarian flatworms. These animals have long been regarded as champion regenerators because they can rapidly replace any tissue that’s been damaged or lost, including the nervous system. The basis of this unlimited renewal lies in an abundant population of stem cells. My lab’s primary goals are to understand how these cells sense and respond to injury, and how they maintain genome integrity through repeated cell divisions that occur during regeneration.

Check out the seminar here!

Dr. Carrie Adler | Adler Lab

Bio:

Carrie is currently an Assistant Professor in the Department of Molecular Medicine at Cornell University, where she started her lab in 2015. She attended college at Wesleyan University and afterwards worked as a technician with Bruce Mayer at Harvard Medical School, studying signal transduction pathways. For graduate school, Carrie enrolled in the Tetrad program at UCSF, joining Cori Bargmann's lab to study neural development in C. elegans. As a postdoc, Carrie trained with Alejandro Sánchez Alvarado at the University of Utah and the Stowers Institute for Medical Research.

Abstract:

Throughout our lives, we are constantly exposed to insults, including injuries, disease, and environmental toxins. Frequently referred to as a ‘fountain of youth’ given their potential for rejuvenation, stem cells have the capacity to restore damaged tissue. In most model organisms, regenerative capacity is limited and stem cells are scarce, which has made it difficult to pinpoint the mechanisms regulating their behavior. In addition, stem cell exhaustion occurs as we age, diminishing our ability to repair damaged tissues. Finally, while we have made significant progress in recapitulating organ growth in vitro, how might these tissues be used in humans to restore physiological function?

My research program has probed these questions in an emerging model organism, planarian flatworms. These animals have long been regarded as champion regenerators because they can rapidly replace any tissue that’s been damaged or lost, including the nervous system. The basis of this unlimited renewal lies in an abundant population of stem cells. My lab’s primary goals are to understand how these cells sense and respond to injury, and how they maintain genome integrity through repeated cell divisions that occur during regeneration.

Check out the seminar here!

 Dr. Sarah Tishkoff | Tishkoff Lab

Sarah Tishkoff is the David and Lyn Silfen University Professor in Genetics and Biology at the University of Pennsylvania, holding appointments in the School of Medicine and the School of Arts and Sciences. She is also Director of the Penn Center for Global Genomics and Health Equity.

Dr. Tishkoff studies genomic and phenotypic variation in ethnically diverse Africans. Her research combines field work, laboratory research, and computational methods to examine African population history and how genetic variation can affect a wide range of traits – for example, why humans have different susceptibility to disease, how they metabolize drugs, and how they adapt through evolution.

Dr. Tishkoff is a member of the National Academy of Sciences and a recipient of an NIH Pioneer Award, a David and Lucile Packard Career Award, a Burroughs/Wellcome Fund Career Award, an ASHG Curt Stern award, and a Penn Integrates Knowledge (PIK) endowed chair. She is a member of the Scientific Advisory Panel for the Packard Fellowships for Science and Engineering and the Board of Global Health at the National Academy of Sciences and is on the editorial boards at PLOS Genetics, Genome Research; G3 (Genes, Genomes, and Genetics);Cell.

Her research is supported by grants from the National Institutes of Health, the National Science Foundation, the Chan Zuckerberg Institute, and the American Diabetes Association.

Abstract:

Africa is the ancestral homeland of all modern human populations within the past 300,000 years.  It is also a region of tremendous cultural, linguistic, climatic, phenotypic and genetic diversity.   Despite the important role that African populations have played in human history, they remain one of the most underrepresented groups in human genomics studies. A comprehensive knowledge of patterns of variation in African genomes is critical for a deeper understanding of human evolutionary history and the identification of functionally important genetic variation that plays a role in both normal variation and disease risk.  Here I will describe our studies of genomic variation in ethnically and geographically diverse Africans in order to reconstruct human evolutionary history and identify candidate genes that play a role in adaptation to infectious disease, diet, high altitude, stature, and skin color. I will highlight recent research integrating data from a genome wide association study of skin pigmentation in Africans and scans of natural selection from whole genome sequencing. Combining high-throughput reporter assays, Hi-C, CRISPR-based editing, and melanin content assays, we identified novel regulatory variants that impact melanin levels in vitro and modulate human skin color variation. Additionally, we identified a novel gene regulating pigmentation by impacting genes involved in oxidative phosphorylation and melanogenesis. These results provide insights into the mechanisms underlying human skin color diversity and adaptive evolution.

Watch the seminar here!

 Dr. Sarah Tishkoff | Tishkoff Lab

Sarah Tishkoff is the David and Lyn Silfen University Professor in Genetics and Biology at the University of Pennsylvania, holding appointments in the School of Medicine and the School of Arts and Sciences. She is also Director of the Penn Center for Global Genomics and Health Equity.

Dr. Tishkoff studies genomic and phenotypic variation in ethnically diverse Africans. Her research combines field work, laboratory research, and computational methods to examine African population history and how genetic variation can affect a wide range of traits – for example, why humans have different susceptibility to disease, how they metabolize drugs, and how they adapt through evolution.

Dr. Tishkoff is a member of the National Academy of Sciences and a recipient of an NIH Pioneer Award, a David and Lucile Packard Career Award, a Burroughs/Wellcome Fund Career Award, an ASHG Curt Stern award, and a Penn Integrates Knowledge (PIK) endowed chair. She is a member of the Scientific Advisory Panel for the Packard Fellowships for Science and Engineering and the Board of Global Health at the National Academy of Sciences and is on the editorial boards at PLOS Genetics, Genome Research; G3 (Genes, Genomes, and Genetics);Cell.

Her research is supported by grants from the National Institutes of Health, the National Science Foundation, the Chan Zuckerberg Institute, and the American Diabetes Association.

Abstract:

Africa is the ancestral homeland of all modern human populations within the past 300,000 years.  It is also a region of tremendous cultural, linguistic, climatic, phenotypic and genetic diversity.   Despite the important role that African populations have played in human history, they remain one of the most underrepresented groups in human genomics studies. A comprehensive knowledge of patterns of variation in African genomes is critical for a deeper understanding of human evolutionary history and the identification of functionally important genetic variation that plays a role in both normal variation and disease risk.  Here I will describe our studies of genomic variation in ethnically and geographically diverse Africans in order to reconstruct human evolutionary history and identify candidate genes that play a role in adaptation to infectious disease, diet, high altitude, stature, and skin color. I will highlight recent research integrating data from a genome wide association study of skin pigmentation in Africans and scans of natural selection from whole genome sequencing. Combining high-throughput reporter assays, Hi-C, CRISPR-based editing, and melanin content assays, we identified novel regulatory variants that impact melanin levels in vitro and modulate human skin color variation. Additionally, we identified a novel gene regulating pigmentation by impacting genes involved in oxidative phosphorylation and melanogenesis. These results provide insights into the mechanisms underlying human skin color diversity and adaptive evolution.

Watch the seminar here!